C the Signs, a London, UK-based AI-powered cancer detection platform, has secured $8 million in funding. 

Investors 

The investment comes from Khosla Ventures, a venture capital firm that supports entrepreneurs in AI, sustainability, enterprise, consumer, health, and frontier technologies. With over $15 billion in assets under management (AUM), the firm invests in early- to growth-stage companies, focusing on bold, transformative technologies. 

C the Signs Use of Funds 

With the new funding, C the Signs aims to accelerate the deployment of its technology in the U.S. 

About C the Signs 

Founded in 2017 by Bhavagaya Bakshi and Miles Payling, C the Signs has developed an AI-powered cancer prediction system that identifies patients at risk of cancer at its earliest and most treatable stage. The company's platform uses patient data from electronic health records, incorporating a wide range of personal and environmental data points beyond basic indicators like age and gender. 

Funding Details 

Company: C the Signs Limited 

Raised: $8.0M 

Round: Unknown 

Funding Date: January 2025 

Investor: Khosla Ventures 

Company Website: https://www.cthesigns.com/  

Software Category: AI Cancer Detection 

Source: https://www.businesswire.com/news/home/20250129748639/en